Clinical Trials Logo

Genital Wart Virus Infection clinical trials

View clinical trials related to Genital Wart Virus Infection.

Filter by:
  • None
  • Page 1

NCT ID: NCT03901690 Recruiting - Clinical trials for Genital Wart Virus Infection

Betaglucin 0.2% Versus Imiquimod 5% in Treatment of Ano-genital Warts: Combined Results From Triple Blind Controlled Study

BETAGENWART
Start date: August 27, 2019
Phase: Phase 3
Study type: Interventional

In order to determine the Efficacy of Betaglucin 0.2% in gel vs Imiquimod 5% cream in the treatment of 102 individuals older than 18 years with anogenital warts trials in two arms 51 with Betaglucin 0.2% and 51 with Imiquimod 5%.